Ethic Inc’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.76M | Sell |
81,348
-4,573
| -5% | -$549K | 0.17% | 118 |
|
|
2025
Q1 | $9.42M | Sell |
85,921
-33,752
| -28% | -$3.7M | 0.19% | 112 |
|
|
2024
Q4 | $11.6M | Sell |
119,673
-13,074
| -10% | -$1.27M | 0.24% | 81 |
|
|
2024
Q3 | $12.8M | Sell |
132,747
-8,210
| -6% | -$794K | 0.32% | 58 |
|
|
2024
Q2 | $15M | Buy |
140,957
+8,210
| +6% | +$874K | 0.35% | 48 |
|
|
2024
Q1 | $12.8M | Buy |
132,747
+7,987
| +6% | +$773K | 0.32% | 58 |
|
|
2023
Q4 | $12.6M | Buy |
124,760
+11,780
| +10% | +$1.19M | 0.37% | 42 |
|
|
2023
Q3 | $11.5M | Buy |
112,980
+13,489
| +14% | +$1.37M | 0.4% | 35 |
|
|
2023
Q2 | $10M | Sell |
99,491
-1,612
| -2% | -$163K | 0.37% | 41 |
|
|
2023
Q1 | $9.3M | Sell |
101,103
-2,691
| -3% | -$248K | 0.38% | 43 |
|
|
2022
Q4 | $9.42M | Buy |
103,794
+33,521
| +48% | +$3.04M | 0.51% | 31 |
|
|
2022
Q3 | $5.34M | Sell |
70,273
-11,612
| -14% | -$883K | 0.36% | 56 |
|
|
2022
Q2 | $6.92M | Buy |
81,885
+4,598
| +6% | +$389K | 0.48% | 33 |
|
|
2022
Q1 | $6.78M | Buy |
77,287
+37,008
| +92% | +$3.25M | 0.47% | 31 |
|
|
2021
Q4 | $3.52M | Buy |
40,279
+3,564
| +10% | +$312K | 0.27% | 86 |
|
|
2021
Q3 | $3M | Buy |
36,715
+12,850
| +54% | +$1.05M | 0.31% | 76 |
|
|
2021
Q2 | $2.18M | Buy |
23,865
+12,675
| +113% | +$1.16M | 0.26% | 87 |
|
|
2021
Q1 | $957K | Buy |
11,190
+2,162
| +24% | +$185K | 0.17% | 160 |
|
|
2020
Q4 | $853K | Buy |
9,028
+3,890
| +76% | +$368K | 0.23% | 108 |
|
|
2020
Q3 | $447K | Sell |
5,138
-221
| -4% | -$19.2K | 0.17% | 149 |
|
|
2020
Q2 | $468K | Buy |
5,359
+2,565
| +92% | +$224K | 0.27% | 110 |
|
|
2020
Q1 | $230K | Buy |
+2,794
| New | +$230K | 0.19% | 164 |
|